Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating Expenses:
Selling, general and administrative expenses	$ 11,164,858	$ 4,882,877
Research and development expenses	5,727,645	4,252,249
Loss from Operations	(16,892,503)	(9,135,126)
Other (Income) Expense:
Gain on extinguishment of note payable	(312,700)
Interest (income) expense, net	(18,709)	(3,739)
Change in fair value of derivative liabilities		(211,807)
Other (income) expense	(33,272)	215,906
Total Other (Income) Expense	(364,681)	360
Net Loss	(16,527,822)	(9,135,486)
Deemed dividend to Series C Preferred Stockholders		(607,220)
Net Loss Attributable to Common Stockholders	$ (16,527,822)	$ (9,742,706)
Net Loss Per Basic and Diluted Common Share:	$ (1.90)	$ (7.54)
Weighted Average Number of Common Shares Outstanding:
Basic and Diluted	8,679,824	1,291,469